Prevention of HIV infection

Details Prevention of HIV infection Prevention of HIV infection

1995-06-22

1997-07-08

Travers, Russell

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

514934, A16K 3113

Patent

active

056461895

ABSTRACT:
Topical application of cysteamine, cystamine, or phosphocysteamine to an appropriate bodily portion of a human is effective for the prevention of HIV infection.

REFERENCES:
patent: 3892824 (1975-07-01), Piper et al.
patent: 3991190 (1976-11-01), Garzia et al.
patent: 5554655 (1996-09-01), Thoene
O. Yamamoto et al, Chemical Abstracts 113:55076m, "Low-Dose-Rate Effect of Tritium Beta-Rays on Transfection Activity of Phage DNA Related to an Oxidative Species different from .OH, HO.sub.2. O.sub.2 -. and Hydrogen Peroxide" 1990.
Wainberg, Mark et al, Chemical Abstracts 112:48337y, "Inactivation of Human Immunodeficiency Virus Type 1 in Tissue Culture Fluid and in Genital Secretions by the Spermicide Benzalkonium Chloride" 1990.
E.B. Michaels et al, Chemical Abstracts 117:258256a, "Pharmaceutical Composition for Inactivating Enveloped Viruses and Sperm" 1992.
Windholtz, "The Merck Index", 10th Edition, Published 1983 by Merck & Co., Inc.--Items 2773, 2775 and 2776.
V.V. Bartsevich et al, Chemical Abstracts 113:55075k, "Modifying Effect of Glycerol and Cysteamine on .gamma.-Radiation Induction of .lambda. Prophage in E. coli Cells" 1990.
T. Kalebic et al, Proc. Natl. Acad. Sci. USA, "Suppression of Human Immunodeficiency Virus Expression in Chronically Infected Monocytic Cells by Glutathione, Glutathione Ester, and N-Acetylcysteine", vol. 88, pp. 986-990, (1991).
R. Djurhuus et al, Carcinogenesis, "Modulation of Glutathione Content and the Effecton Methionine Auxotrophy and Cellular Distribution of Homocysteine and Cysteine in Mouse Cell Lines", vol. 12, pp. 241-247, (1991).
R.S. Shulof et al, Arzneimittal Forschung, "Treatment of HTLV-III/LAV-Infection Patients with D-Penicillamine", vol. 36, pp. 1531-1534, (1986).
S. Kubota et al, Aids Research and Human Retroviruses, "2,3 Dimercapto-1-Propanol Inhibits HIV-1 tat Activity, Viral Production and Infectivity in Vitro", vol. 6, pp. 919-927, (1990).
J.S. Oxford et al, Chemical Abstracts 78:119655t, "Inhibitor of the Particle-Associated RNA-Dependent RNA Polymerase of Influenza A and B Viruses" 1973.
Chemical Abstracts 85:28782k, "Composition OFR Treatment of Virus Infections" 1976.
J.G. Thoene, Clinical Research, "In-Vitro Effectiveness of Aminothols and Disulfides Against HIV-1", vol. 40, p. 246A, Apr. 1992.
J. Cohen, Science, "Somber News from the AIDS Front", vol. 260, pp. 1712-1713, (1993).
P.S. Sarin et al, Chemical Abstracts 107:108862z, "Inhibition of HTLV-III Replication in Cell Cultures" 1986.
A. Garzia et al, Chemical Abstracts 84:155677j, "Composition for Treatment of Virus Infections" 1976.
J. Gainer et al, Chemical Abstracts 75:85659t, "Inactivation of the Pseudorabies Virus by Dithiothreitol" 1986.
P.S. Sarin et al, Nato ASI Ser., "Inhibition of HTLV-III Replicationi n Cell Cultures", vol. 120, pp. 329-342 (1986).
Fields Virology, 2nd Ed., B.N. Fields, et al, Eds., Raven Press, NY, vol. 1, pp.1075-1089 (1990).
Fields Virology, 2nd Ed. B.N. Fields, et al. Eds. Raven Press, NY, vol. 2, pp. 1437-1440, 1452-1477, (1990).
Fields Virology, 2nd Ed. B.N. Fields, et al. Eds. Raven Press, NY, vol. 1, pp. 507-548 (1990).
Fields Virology, 2nd Ed., B.N. Fields, et al, Eds., Raven Press, NY, vol. 2, pp. 1787-1790 (1990).
Fields Virology, 2nd Ed. B.N. Fields, et al. Eds. Raven Press, NY, vol. 2, pp. 1529-1543, (1990).
Dagani, C&EN, Nov. 23, 1987, pp. 41-49.
Droge et al, Am. J. Med., vol. 91, pp. 140S-144S, (1991).
Mihm et al, AIDS, vol. 5, pp. 497-503 (1991).
Perrin et al, Pharmac. Ther., vol. 12, pp. 255-297 (1981).
Pompei et al, Experientia, vol. 33, pp. 1151-1152 (1977).
La Colla et al, Ann. NY Acad. Sci., vol. 284, pp. 294-304 (1977).
La Colla et al, Experientia, vol. 31, pp. 797-798 (1975).
Marcialis et al, Experientia, vol. 29, pp. 1559-1661 (1973).
Schivo et al, Experientia, vol. 32, pp. 911-913 (1976).
Billard et al, Antimicrobial Agents and Chemotherapy, vol. 5, pp. 19-24 (1974).
M.S. Marcialis et al, Experientia, vol. 30, pp. 1272-1273 (1974).
Staal et al, The Lancet, vol. 339, pp. 909-912 (1992).
Roederer et al, Proc. Natl. Acad. Sci. USA, vol. 87, pp. 4884-4888, (1990).
Oxford et al, J. Gen. Virol., vol. 18, pp. 11-19 (1973).
Oxford et al, Ann. NY Acad., vol. 284, pp. 613-623 (1977).
Arora et al, Can. J. Biochem., vol. 58, pp. 67-72 (1980).
Pisoni et al, J. Bio. Chem., vol. 260, No. 8, pp. 4791-4798 (1985).
Thoene et al, J. of Ped., vol. 96, No. 6, pp. 1043-1044 (1980).
Thoene et al, J. Clin. Invest., vol. 58, pp. 180-189 (1976).
Gliniak et al, J. Bio. Chem., vol. 266, No. 34, pp. 22991-22997 (1991).
Leonard et al, J. Bio. Chem., vol. 265, No. 18, pp. 10373-10382 (1990).
Lekutis et al, J. Acq. Imm. Def. Syn., vol. 5, pp. 78-81 (1992).
Papadopulos-Eleopulos et al, The Lancet, vol. 338, pp. 1013-1014 (1991).
Cardin et al, J. Bio. Chem., vol. 266, No. 20, pp. 13355-13363 (1991) (Abstract).
Kim et al, Biochem. Biophys. Res. Comm., vol. 179, No. 3, pp. 1614-1619 (1991).
Gahl et al, New Engl. J. Med., vol. 316, pp. 971-977 (1987).
Wilson et al, J. Am. Chem. Soc., vol. 102, pp. 359-363 (1980).
Smolin et al, Ped. Res., vol. 23, No. 6, pp. 616-620 (1988).
Owens et al, Virology, vol. 179, pp. 827-833 (1990).
Willey et al, Proc. Natl. Acad. Sci, USA, vol. 85, pp. 9580-9584 (1988).
Dedera et al, J. Vir., vol. 65, No. 11, pp. 6129-6136 (1991).
Harakeh et al, Am. Clin. Nutr., vol. 54, pp. 1231S-1235S (1991).
Bacq, Chemical Protection Against Ionizing Radiation, IV, "The Protective Compounds", pp. 16-35, Charles C. Thomas, USA.
Thoene, "Orphan Drugs and Orphan Diseases: Clinical Realities and Public Policy", pp. 125-131, Alan R. Liss, Inc., NY 1983.
Thoene, "Cooperative Approaches to Research and Development of Orphan Drugs", pp. 157-162, Alan R. Liss, Inc., 1985.
Turner, Med. J. Austral., vol. 153, p. 502 (1990).
Bergamini et al, J. Clin. Invest., vol. 93, pp. 2251-2257 (1994).
Ryser et al, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 4559-4563 (1994).
Schroeder et al, CA 110: 1815e 1989.
Hotz et al, CA 81: 101420q 1974.
CA 78: 119655t 1973.
CA 85: 28782k 1976.
CA 113: 55076m 1990.
CA 112: 48337y 1990.
CA 117: 258256a 1992.
Windholtz, "The Merck Index", 10th edition, published 1983 by Merck & Co., Inc. items 2773, 2775 and 2776 1983.
CA 113: 55075k 1990.
Oxford 78CA: 119655t, 1973.
Bartsevich et al. 113CA: 55075k, 1990.
Wainburg et al. 112CA: 48337y, 1990.
Merk Index 10th Ed #2771 & 2776.
Istituto Chemioterapico Italiano, CA 85: 28728k, 1976.

Affiliated with

Also associated with

Rating

Prevention of HIV infection does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention of HIV infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of HIV infection will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2409184